Benzodiazepine-GABAA receptor complex ligands in two models of anxiety

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of neural transmission

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/BF01291890PMID 9444572
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological characterization of benzodiazepine receptor ligands with intrinsic efficacies ranging from high to zero

  2005cited by this paper
• The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands

  1996cited by this paper
• The effects of repeated administration of diazepam, MK-801 and CGP 37849 on rat behavior in two models of anxiety.

  1996cited by this paper
• Putative benzodiazepine partial agonists demonstrate receptor heterogeneity.

  1996cited by this paper
• Distribution of [3H]zolpidem binding sites in relation to messenger RNA encoding the alpha 1, beta 2 and gamma 2 subunits of GABAA receptors in rat brain.

  1995cited by this paper
• Biological function of GABAA/benzodiazepine receptor heterogeneity.

  1995cited by this paper
• Distribution of [3H]zolpidem binding sites in relation to messenger RNA encoding the α1, β2 and γ2 subunits of GABAA receptors in rat brain

  1995cited by this paper
• Pharmacology of tolerance to benzodiazepine receptor ligands.

  1995cited by this paper
• Abecarnil enhances GABA-induced currents in acutely isolated cerebellar Purkinje cells.

  1995cited by this paper
• Anxiolytic Potential of Benzodiazepine Receptor Partial Agonists

  1994cited by this paper
• Effects of antagonists at the NMDA receptor complex in two models of anxiety.

  1994cited by this paper
• Imidazenil, a partial positive allosteric modulator of GABAA receptors, exhibits low tolerance and dependence liabilities in the rat.

  1994cited by this paper
• Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies

  1994cited by this paper
• Regional differences in rat benzodiazepine binding in response to novelty and cat odour.

  1994cited by this paper
• Pharmacological characterization of the novel anxiolytic beta-carboline abecarnil in rodents and primates.

  1994cited by this paper
• Evidence for central benzodiazepine receptor heterogeneity from behavior tests.

  1994cited by this paper
• Long-term treatment with abecarnil fails to induce tolerance in mice.

  1994cited by this paper
• Full and partial agonism displayed by benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes.

  1993cited by this paper
• Comparative autoradiographic distribution of central omega (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem.

  1993cited by this paper
• Abecarnil is a full agonist at some, and a partial agonist at other recombinant GABAA receptor subtypes.

  1993cited by this paper
• The comparison of benzodiazepine derivatives and serotonergic agonists and antagonists in two animal models of anxiety.

  1992cited by this paper
• Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic.

  1992cited by this paper
• Pharmacological and Behavioral Profile of Alpidem as an Anxiolytic

  1990cited by this paper
• Effects of drugs on punished behavior: pre-clinical test for anxiolytics.

  1990cited by this paper
• Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors.

  1990cited by this paper
• Pharmacokinetics of amitriptyline and amitriptylinoxide after intravenous or oral administration in humans.

  1988cited by this paper
• Ro 16-6028: A Novel Anxiolytic Acting as a Partial Agonist at the Benzodiazepine Receptor

  1988cited by this paper

• Anxiolytic-Like Effects of Bergamot Essential Oil Are Insensitive to Flumazenil in Rats

  2019cites this paper
• Therapeutical doses of ivermectin and its association with stress disrupt motor and social behaviors of juvenile rats and serotonergic and dopaminergic systems.

  2019cites this paper
• The Hippocampus and Panic Disorder: Evidence from Animal and Human Studies

  2016cites this paper
• Development and characterisation of a novel preclinical test battery for detecting anxiolytic and antidepressant properties of drugs

  2016cites this paper
• Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse

  2015cites this paper
• Marine polyphenol phlorotannins promote non-rapid eye movement sleep in mice via the benzodiazepine site of the GABAA receptor

  2014cites this paper
• Effects of zolpidem on sedation, anxiety, and memory in the plus-maze discriminative avoidance task

  2013cites this paper
• Evaluación del efecto de líquido amniótico humano y sus ácidos grasos en ratas sometidas a modelos experimentales de ansiedad.

  2013cites this paper
• Risperidone ameliorates post-traumatic stress disorder-like symptoms in modified stress re-stress model.

  2013cites this paper
• Homeopathic Doses of Gelsemium sempervirens Improve the Behavior of Mice in Response to Novel Environments

  2011influential citation
• Effects of high-dilutions in behavioural models: a commentary on critical issues, from reproducibility to plausibility

  2011cites this paper
• Use of the light-dark box to compare the anxiety-related behavior of virgin and postpartum female rats.

  2011cites this paper
• Anxiolytic effects of Dolichandrone falcata Seem., Bignoniaceae, stem-bark in elevated plus maze and marble burying test on mice

  2010cites this paper
• Current concept of anxiety: implications from Darwin to the DSM-V for the diagnosis of generalized anxiety disorder

  2010cites this paper
• Expression of α-synuclein is increased in the hippocampus of rats with high levels of innate anxiety

  2009cites this paper
• Neonatal allopregnanolone increases novelty‐directed locomotion and disrupts behavioural responses to GABAA receptor modulators in adulthood

  2009cites this paper
• Strain- and model-dependent effects of chlordiazepoxide, L-838,417 and zolpidem on anxiety-like behaviours in laboratory mice.

  2008cites this paper
• Possible GABAergic Modulation in the Protective Effect of Zolpidem in Acute Hypoxic Stress-induced Behavior Alterations and Oxidative Damage

  2008cites this paper
• MOTHER-INFANT TOUCH, NEUROCHEMISTRY, AND POSTPARTUM ANXIETY

  2008cites this paper
• Quercetin Protects Against Acute Immobilization Stress-Induced Behaviors and Biochemical Alterations in Mice

  2008cites this paper
• Effect of Intra-Amygdala Injection of Nicotine and GABA Receptor Agents on Anxiety-Like Behaviour in Rats

  2008cites this paper
• Protective effect of alprazolam in acute immobilization stress-induced certain behavioral and biochemical alterations in mice.

  2007cites this paper
• Possible involvement of GABAergic modulation in the protective effect of gabapentin against immobilization stress‐induced behavior alterations and oxidative damage in mice

  2007cites this paper
• Influence of diltiazem on the behavior of zolpidem-treated mice in the elevated-plus maze test

  2007cites this paper
• Possible involvement of GABA A-benzodiazepine receptor in the anxiolytic-like effect induced by Passiflora actinia extracts in mice.

  2007cites this paper
• Positive association between ethanol consumption and anxiety-related behaviors in two selected rat lines.

  2007cites this paper
• Pharmacological and computational analysis of alpha-subunit preferential GABA(A) positive allosteric modulators on the rat septo-hippocampal activity.

  2007cites this paper
• Protective effect of non-selective and selective COX-2-inhibitors in acute immobilization stress-induced behavioral and biochemical alterations.

  2007cites this paper
• Characterization in Rats of the Anxiolytic Potential of ELB139 [1-(4-Chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a New Agonist at the Benzodiazepine Binding Site of the GABAA Receptor

  2005cites this paper
• A comparison of chlordiazepoxide, bretazenil, L838,417 and zolpidem in a validated mouse Vogel conflict test

  2005cites this paper
• Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and β-CCt

  2005cites this paper
• Midazolam inhibits neophobia-induced Fos expression in the rat hippocampus

  2005cites this paper
• High and low rearing subgroups of rats selected in the open field differ in the activity of K+-stimulated p-nitrophenylphosphatase in the hippocampus.

  2005cites this paper
• Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.

  2005cites this paper
• Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.

  2004cites this paper
• In Vivo Pharmacological Characterization of Indiplon, a Novel Pyrazolopyrimidine Sedative-Hypnotic

  2004cites this paper
• Differential actions of diazepam and zolpidem in basolateral and central amygdala nuclei.

  2004cites this paper
• Effects of drugs that potentiate GABA on extinction of positively-reinforced operant behaviour.

  2004cites this paper
• Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and β-CCt

  2004cites this paper
• The neurobiology and control of anxious states.

  2003cites this paper
• Genetic Selection of Two New Rat Lines Displaying Different Levels of Anxiety-Related Behaviors

  2003cites this paper
• The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review.

  2003cites this paper
• Evaluation of Lewis and SHR rat strains as a genetic model for the study of anxiety and pain.

  2002cites this paper
• The experimental pharmacotherapy of benzodiazepine withdrawal.

  2002cites this paper
• Use of negatively reinforcing electrical brain stimulation to detect conventional and nonconventional anxiolytics as well as an anxiogenic drug.

  2001cites this paper
• Behavioural effects of a benzodiazepine receptor partial agonist, Ro 19‐8022, in the social conflict test in mice

  2000cites this paper
• The influence of serotonin depletion on rat behavior in the Vogel test and brain 3H-zolpidem binding

  1999cites this paper
• Pharmacological evaluation of a modified conflict procedure: punished drinking in non-water-deprived rats

  1999cites this paper
• The role of the hippocampus and 5-HT/GABA interaction in the central effects of benzodiazepine receptor ligands

  1999cites this paper
• Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis axis in SHR and WKY rats.

  1999cites this paper
• Identification of female-specific QTLs affecting an emotionality-related behavior in rats

  1999cites this paper
• The Pharmacology and Mechanism of Action of Zolpidem.

  1998cites this paper